The ID/EIS joint fellowship program streamlines a career path for applicants interested in both the ID fellowship and EIS program. The joint ID/EIS fellowship uses the existing EIS and ID fellowship applications, and applicants must apply separately to both the EIS and the ID fellowship programs.
The joint fellowship provides a pathway to leadership roles with CDC, state and local health departments, the Indian Health Service, hospital epidemiology, pharmaceutical companies, academia and in media.
Select from the categories below to learn more about joint fellowship eligibility, the application process, and upcoming informational sessions.
Applicants must submit the EIS application before the EIS deadline and the ID fellowship application separately in ERAS before moving on to the Match process in NRMP. The EIS application for 2023 closed on June 5, 2023. Applicants to the joint fellowship in EIS must also apply to a joint fellowship track in ERAS at a participating ID fellowship institution to complete their joint fellowship application.
If you plan to apply in the future, visit the CDC EIS site to learn more about their application process and requirements. Review the participating ID fellowship websites for their application process and requirements. Additionally, you can view past Q&A webinars, from Sept. 26, 2022 and Dec. 5, 2022 and visit the EIS website for planned EIS-specific webinars.
Eleven ID fellowship programs, listed below, were selected for the first year of the ID/EIS pilot with the first round of candidates applying in early 2023. Learn about the ID fellowship programs, including specific opportunities, eligibility requirements, salary information and more, at the links below.
The joint ID/EIS fellowship pilot program is funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The information on this page does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.